How to Acquire a Second Imaging Center: The Financial Roadmap
A single-center SE Florida imaging operator running $4.2M of revenue and $720K of EBITDA called us last quarter. He had been approached about a second center 11 miles away — $5.5M revenue, $1.05M EBITDA, owner retiring, asking price floating around 5x EBITDA. He had a banker pitching SBA, a broker pitching the deal, and a tax preparer pitching an installment sale. He had three months of exclusivity and no integrated framework for thinking about whether the deal made sense.
This article is the framework he ended up using. It is the financial roadmap for acquiring a second imaging center in SE Florida — valuation logic, deal structure choices, debt-stack engineering, integration economics, and the 90-day post-close playbook. It assumes the operator already runs one functional center and is making the highest-stakes capital-allocation decision of their career.
Key Takeaway: Acquiring a second imaging center is a five-decision problem, not a one-decision problem. The decisions, in order: (1) is the seller's EBITDA real, (2) is the multiple right for the deal characteristics, (3) is the deal structure tax-efficient and risk-aware, (4) is the debt stack survivable under stress, and (5) is the integration plan funded with realistic integration capex. Most single-center operators get burned because they spend 80% of their attention on decision 2 (the multiple) and 5% on decisions 4 and 5 (debt service and integration), which is exactly the inverted weighting. The real make-or-break of a second-center acquisition is the post-close 18 months, not the LOI.
Decision 1 — Is the Seller's EBITDA Real?
The single biggest source of value destruction in imaging-center acquisitions is buying against a seller-EBITDA number that doesn't survive normalization.
A seller's stated EBITDA at SE Florida imaging centers in 2026 typically requires three categories of normalization:
Owner-related add-backs: Most legitimately survive scrutiny. Owner W-2 above market rate, personal vehicle expense, family-on-payroll outside operational roles, owner travel and entertainment that is not customer-facing. A buyer should add these back to seller EBITDA and re-run the multiple math against normalized figures.
One-time vs recurring distinction: Equipment purchases miscategorized as repairs, marketing campaigns associated with a one-time location launch, legal expense from a closed dispute. These should add back. But beware of seller representations that recurring expenses are "one-time": a 4-year history of "one-time legal" usually isn't.
Revenue durability adjustments: This is the under-examined category. A center may report $5.5M of revenue, but if 18% of that revenue is tied to a single referring physician retiring next year, an LOP exposure with a deteriorating yield curve, or a payer-mix anomaly that won't repeat, the forward-looking EBITDA is materially below the trailing-12-month figure. Most LOI conversations price off TTM EBITDA without a forward-revenue durability test. The buyer eats the gap.
The reasonable target: walk into LOI negotiation with a normalized EBITDA estimate that is the buyer's, not the seller's. Build the bridge from seller-stated EBITDA to buyer-modeled forward EBITDA explicitly. Negotiate the multiple against the buyer-modeled number.
Decision 2 — Is the Multiple Right?
SE Florida single-center imaging EBITDA multiples in 2026 typically run in the following bands, depending on deal characteristics:
| Center Profile | Typical Multiple |
|---|---|
| Single-center, soft revenue, aging equipment, payer-mix risk | 2.5x–3.5x |
| Single-center, stable revenue, modern equipment, balanced mix | 3.5x–4.5x |
| Single-center, growing revenue, premium equipment, clean mix | 4.5x–5.5x |
| Strategic / tuck-in to existing platform | 5.0x–6.5x |
| Multi-center platform sale | 5.5x–8.0x+ |
The multiple is always a band, not a number. The right multiple inside the band depends on:
- Revenue durability — single-referrer concentration drops the multiple, diversified referral base raises it
- Payer-mix quality — high LOP/PIP exposure drops the multiple, clean Medicare/commercial mix raises it
- Equipment age — recently re-equipped centers carry better multiples than centers facing imminent capex
- Real-estate situation — owned vs leased, lease terms, whether the seller also owns the building
- Location density — overlap with the buyer's existing patient draw can be either dilutive or accretive depending on referral patterns
For a longer treatment of the underlying multiple drivers across SE Florida imaging, see Multi-Center Imaging Owner Income: 2026 SE Florida Benchmarks.
Decision 3 — Asset Deal vs Stock Deal vs Hybrid
The legal structure of a small-imaging-center acquisition is rarely a stock deal. The standard SE Florida structure is an asset purchase — the buyer entity purchases agreed-on operating assets, assumes specifically identified liabilities, and leaves the seller's legal entity (and its historical contingent liabilities) behind.
The asset-deal structure has three significant tax-and-risk implications worth understanding before LOI:
- Buyer gets a step-up in basis on acquired assets, which produces ongoing depreciation deductions that are economically valuable. The allocation of purchase price across asset classes (IRS Form 8594, Asset Acquisition Statement) is jointly negotiated and matters substantially for both parties' tax positions.
- Seller faces ordinary-income recapture on equipment and depreciation recapture, plus capital-gains treatment on goodwill. The buyer's preferred allocation (heavy on tangible assets and equipment, lighter on goodwill) is the seller's least favorite (capital gains treatment on goodwill is preferred). Allocation negotiation is a real economic piece of the deal.
- Liability isolation — buyer takes only the liabilities specifically assumed in the purchase agreement. Pre-closing exposure (malpractice, employment disputes, payer audits, billing-company disputes) stays with the seller's entity. This is the structural reason asset deals dominate at this scale.
A stock deal at this scale is typically only used when an unassignable contract (such as a unique payer agreement) makes asset transfer impractical. When stock deals do happen, robust reps-and-warranties indemnification becomes essential — and the price usually reflects the additional risk the buyer is absorbing.
Decision 4 — The Debt Stack
The most common single-center-to-second-center deal structure in SE Florida 2026 is some combination of:
- Conventional bank debt secured against business assets and personal guarantees
- SBA 7(a) loan, often in the $1M–$5M range, with longer amortization than conventional debt (SBA 7(a) program details)
- Seller financing, typically 10–25% of the purchase price, structured as a 5-year subordinated note
- Equipment-specific financing for any equipment refresh planned at close
- A/R-backed line of credit to handle working-capital needs during integration
The typical SE Florida structure on a $4.5M acquisition (5x of $900K normalized EBITDA):
| Source | Amount | Notes |
|---|---|---|
| Buyer cash equity | $675,000 | 15% — minimum to satisfy SBA |
| SBA 7(a) loan | $2,925,000 | 65% — 10-year amortization, partial balloon |
| Seller note | $675,000 | 15% — 5-year sub-debt, market interest |
| Working-capital LOC | $225,000 | 5% of TVA, A/R-secured |
| Total | $4,500,000 |
The debt-service coverage ratio is the binding constraint. Pro-forma combined-entity EBITDA needs to cover annual debt service by at least 1.25x for the deal to be lender-approvable, and ideally 1.4x+ for the deal to be operationally survivable through a normal stress event.
A combined-entity pro forma at this scale typically looks like:
- Existing center EBITDA: $720K
- Acquired center normalized EBITDA: $900K (after buyer-side normalization)
- Pro-forma combined EBITDA: $1,620K
- Annual debt service (SBA + seller note): $410K
- Combined DSCR: 3.95x — very strong
The DSCR is the lifeline. An operator going into a second-center acquisition with combined DSCR below 1.4x is leveraging into a fragile structure that doesn't survive a routine bad quarter, a payer-mix shift, or an unexpected equipment failure. Walking away is sometimes the right move.
(For the related framing on DSCR and lender behavior, see Why Your Business Loan Was Denied (And The 60 Percent Rule).)
Decision 5 — The Integration Math
The least-modeled decision in second-center acquisitions is integration capex and operational cost. Most LOIs underweight this dramatically.
A realistic integration budget at SE Florida scale:
- EMR / RIS / PACS migration or integration: $40K–$120K
- Billing-system reconciliation and back-billing cleanup: $25K–$75K
- Equipment compliance / safety inspection / brand alignment: $30K–$90K
- Staff retention bonuses and transition incentives: $50K–$150K
- Dual-running operational expense during transition: $80K–$200K (3–6 months)
- Marketing investment to retain referrer relationships through ownership change: $30K–$80K
- Legal, accounting, and consulting close-out: $40K–$100K
Total realistic integration spend: $295K–$815K on a $4.5M deal. That's 6.5%–18% of purchase price — usually paid out over the first 12 months and rarely included in the financing structure.
Most deals that go sideways do so in this category. The buyer's working-capital LOC gets consumed by integration costs that weren't modeled, the combined-entity EBITDA dips during integration, the DSCR compresses, and the lender starts asking questions.
The fix: model integration explicitly, fund it from a dedicated integration reserve at close (not from operating cash), and hold yourself to the integration budget like a real budget. (For more on growth reinvestment and working-capital discipline, see the related distribution-ratio framing in Why Your Business Loan Was Denied (And The 60 Percent Rule).)
The 90-Day Post-Close Playbook
The first 90 days post-close determine whether the deal compounds or compromises. The playbook:
Day 1–14: Stabilize without disrupting. Retain key staff, reassure key referrers, run the existing schedule unchanged, and meet every team member individually. Do not implement any operational changes in the first two weeks except those legally required.
Day 15–45: Run a Strategic Radiology Review on the acquired center. Per-payer DSO decomposition (see DSO Benchmarks for Imaging Centers), per-modality contribution analysis (see Per-Modality Profitability), and LOP yield-adjusted A/R review (see LOP Economics: Real Yield vs Face Value). The review confirms or refutes the buyer-side normalization assumptions used to value the deal.
Day 30–60: Identify the top three operational improvements that don't require capital. These are typically: tightening front-end demographic and authorization capture, working aged Tier-1 claims that the prior owner's operation had let drift, and PIP reconciliation cadence. Each of these typically returns $50K–$200K of cash with no capex.
Day 45–90: Begin selective system unification. Where the financial logic is clear, integrate billing under one system, consolidate banking, unify the chart of accounts. Where it is not clear, leave it alone for another quarter. Premature integration is a far bigger risk than slow integration.
Day 90: Run a full combined-entity pro forma against the LOI assumptions. Are the DSCR, distribution ratio, and EBITDA on track? If yes, the deal is on the rails. If no, identify the specific gap and the corrective action. The single biggest mistake at this stage is to assume "it will catch up next quarter" when the data is saying it won't.
The Tax Layer
Second-center acquisitions create year-of-acquisition tax planning opportunities that operators should integrate into the deal-structure conversation, not bolt on after close:
- Bonus depreciation and Section 179 — equipment acquired in the deal is eligible for accelerated depreciation, often dramatically reducing year-of-acquisition taxable income. Bonus depreciation continues to phase down in 2026 (IRS Pub 946 / Section 168(k)), so timing decisions matter.
- Cost segregation studies — for any acquired real estate (or significant tenant improvements), a cost-seg study can reclassify portions of the building basis into shorter recovery periods, accelerating depreciation deductions. The economics typically justify the study at acquisition prices above $1M of building/TI cost.
- Goodwill amortization — under IRC Section 197, goodwill is amortized straight-line over 15 years. This is the principal post-close tax shield in most asset-deal acquisitions.
- Section 199A QBI — the buyer's flow-through deduction position improves with acquired EBITDA, but the SSTB rules have nuances at the imaging-center level that should be confirmed with a tax preparer who understands the relevant Treasury regulations.
A properly structured second-center acquisition will produce 18–36 months of meaningfully reduced taxable income through the combination of bonus depreciation, cost segregation, and goodwill amortization. Modeling those tax benefits into the deal economics — not assuming them after the fact — frequently changes the conclusion on which deals are worth doing.
What This Looks Like for an Operator
Your accountant has every number this article requires. Your banker has every number this article requires. Your broker has every number this article requires. The question is whether anyone is integrating valuation, deal structure, debt-stack engineering, integration economics, and the post-close playbook into a single decision framework — instead of running each piece in isolation.
The single-center operator from the opening of this article ran the framework over a 60-day diligence window. The buyer-side normalization knocked the seller's stated $1.05M EBITDA down to $900K — a 14% trim that re-anchored the entire valuation conversation. The integration capex was modeled at $410K (rather than the seller's verbal "low six figures" estimate). The combined DSCR ran at 3.95x at the modeled deal — strong enough to absorb a stress quarter without breaking.
He got the price moved $400K below the original ask, structured 15% as seller financing to keep his cash equity reasonable, and walked into close with a 90-day playbook already written. By day 60 post-close, the per-payer DSO decomposition on the acquired center had revealed $215K of Tier-1 receivables aged 60+ days — clearable in a single billing cycle. The integration came in at $385K, slightly under budget. By month 9, combined-entity EBITDA was running ahead of the pro forma.
Most accounting firms see a deal with a 3.95x DSCR and call it lendable. The operator sees a healthy headline. Both are looking at the same number — and both are missing the same problem. This is what happens when accounting stops looking backward and starts looking forward. (Read how accounting becomes an ROI center, not a cost center.)
The Monday after the deal closed, he told us the most useful artifact wasn't the financial model or the negotiation memo — it was the 90-day playbook. Because that was the document that translated a closed deal into a working business. The work doesn't end at LOI. It barely begins there.
Ready to Run Your Acquisition Framework?
A Strategic Radiology Review is a fixed-fee, two-week engagement that produces buyer-side normalization, valuation modeling, debt-stack engineering, and post-close integration roadmap described in this article — alongside Two Business Unit P&L decomposition, per-payer-class DSO benchmarking, and a banker-grade Intelligence PDF. Built specifically for SE Florida imaging operators evaluating a second-center acquisition, refinancing toward a deal, or preparing for due diligence on an inbound LOI.
Book a Strategic Radiology Review →
Frequently Asked Questions
What multiple should I pay for a second imaging center in SE Florida in 2026? Typical bands: 2.5x–3.5x for soft single-center deals, 3.5x–4.5x for stable single-center, 4.5x–5.5x for growing single-center, and 5.0x–6.5x for strategic tuck-ins to an existing platform. The right multiple inside the band is driven by revenue durability, payer-mix quality, equipment age, real-estate situation, and location overlap with your existing draw.
Should I do an asset deal or a stock deal? Almost always an asset deal at this scale. Asset deals provide step-up in basis, isolate the buyer from pre-closing contingent liabilities, and allow specific liability assumption. Stock deals are typically used only when unassignable contracts (such as unique payer agreements) make asset transfer impractical, and require robust reps-and-warranties indemnification when they do happen.
How much cash equity do I need to put up? SBA 7(a) typically requires 10%–20% buyer equity. Conventional financing requires 20%–35%. With a 10–15% seller note and a working-capital LOC layered in, total buyer cash equity on a $4M–$5M deal usually lands in the $600K–$1.2M range. Cash equity below 10% is uncommon and typically signals deal-structure problems.
What is the right combined-entity DSCR after a second-center acquisition? Lenders require minimum 1.25x. Operationally survivable structures need 1.4x+. Strong structures run 1.7x–2.5x. The 3.95x example in this article is the upper end of the realistic range and reflects the combined-entity scale economics of a successful tuck-in. Going below 1.4x is leveraging into a fragile structure that doesn't survive routine stress.
How long does post-close integration actually take? The 90-day playbook is the active-management window. Full operational integration typically runs 6–12 months. Full financial-system unification typically runs 9–18 months. The most common mistake is to attempt all of it inside the first 90 days, which destabilizes both centers and creates avoidable referrer and staff churn. Slow integration is almost always the right answer.
Disclaimer: This article is for informational purposes only and does not constitute tax, legal, or financial advice. Tax situations vary — consult a qualified tax professional for advice specific to your circumstances. Practice examples are anonymized composites based on real client data; identifying details have been changed.